AI Biomed PredictionsMBRX – Mid-2026 AML unblinding could redefine tiny-cap MBRX valuation ScanScor Admin / April 16, 2026
AI Biomed PredictionsAPVO – Aptevo Set to Transform with Upcoming AML Trial Results ScanScor Admin / July 7, 2025
